News - Healixia

June 2, 2020

Coronavirus: relaxation of paracetamol measures for pharmacists and patients

Heard from FAMHP

Sales of paracetamol remain stable, which is why the restriction of only one box per patient is being lifted. The quotas for pharmaceutical companies and wholesalers have already been abolished. Only the intravenous form remains subject to restriction.

June 2, 2020

The FAMHP web portal - updates to the “My company” and “My activities” applications

Heard from FAMHP

In anticipation of the European regulations on medical devices (Regulation (EU) 2017/745) and in vitro diagnostic medical devices (Regulation (EU) 2017/746), the FAMHP has updated the “My company” and “My activities” applications in its web portal.

June 2, 2020

Coronavirus: extension and relaxation of measures taken by the FAMHP to prevent shortages of medicines

Heard from FAMHP

Coronavirus: verlenging en versoepeling van maatregelen die het FAGG heeft genomen om tekorten aan geneesmiddelen te vermijden

Coronavirus : extension et assouplissement des mesures prises par l'AFMPS pour éviter la pénurie de médicaments

May 14, 2020

Coronavirus: update of guidelines to check the conformity and suitability of surgical mouth masks

Heard from FAMHP

Coronavirus: update van de richtlijnen om de conformiteit en geschiktheid van chirurgische mondmaskers na te gaan

Coronavirus : mise à jour des lignes directrices pour vérifier la conformité et l’aptitude des masques buccaux chirurgicaux

May 7, 2020

Pharmaboardroom.com had a talk with Healixia President Erik Present

PharmaBoardroom, a leading website for C-Level executives working in Healthcare and Life Sciences interviewed Healixia President Erik Present.

May 6, 2020

Coronavirus: national guideline for the management of clinical investigation for medical devices during the coronavirus pandemic

Heard from FAMHP

Coronavirus: nationale richtlijn voor het beheer van klinische onderzoek voor medische hulpmiddelen tijdens de coronaviruspandemie

Coronavirus : ligne directrice nationale pour la gestion d’investigations cliniques sur les dispositifs médicaux durant la pandémie de coronavirus

May 6, 2020

Coronavirus: European Medicines Agency advises continued use of medicines to treat high blood pressure, heart and kidney disease

Heard from FAMHP

Coronavirus: Europees Geneesmiddelenbureau adviseert om geneesmiddelen tegen hoge bloeddruk, hart- en nieraandoeningen te blijven gebruiken

Coronavirus : l’Agence européenne des médicaments recommande de continuer à utiliser les médicaments contre l’hypertension, les maladies cardiaques ou rénales

May 6, 2020

Coronavirus: good practice for changing consumables of ventilation equipment in COVID-19 patients

Heard from FAMHP

Coronavirus: goede praktijken voor het veranderen van verbruiksgoederen van beademingstoestellen bij COVID-19 patiënten

Coronavirus : bonnes pratiques dans le changement des consommables liés au respirateurs des patients COVID -19

May 4, 2020

The impact of COVID 19 on the FAMHP

On 29 April 2020, we organised a webinar 'the impact of COVID 19 on the FAMHP'.

April 20, 2020

Coronavirus: state of supply of hospital drugs

Heard from FAMHP

Coronavirus: stand van zaken van de bevoorrading van geneesmiddelen voor ziekenhuizen

Coronavirus: état des stocks de médicaments hospitaliers